NLS Pharmaceutics NLS Pharmaceutics is a biopharmaceutical company engaged in drug discovery for central nervous system disorders. | ![]() ACADIA Pharmaceuticals ACADIA Pharmaceuticals (formerly Receptor Technologies) is a biopharmaceutical company developing medicines that address medical needs in related central nervous system (CNS) disorders. | |
Founding Date | Founding Date 2019 | Founding Date 1993 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Stans, CH HQ | Locations San Diego, US HQ Princeton, US |
Employees | Employees 6 | Employees 513 |
Valuation ($) | Valuation ($) 10.2 m | Valuation ($) 2.4 b |
Financial | ||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $1.1b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $89m (FY, 2025) |
Gross profit | Gross profit $2.5m (FY, 2024) | Gross profit $982.5m (FY, 2025) |
Net income | Net income ($2m) (FY, 2024) | Net income $391m (FY, 2025) |

ACADIA Pharmaceuticals (formerly Receptor Technologies) is a biopharmaceutical company developing medicines that address medical needs in related central nervous system (CNS) disorders.
View company